|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Madison Dearborn Partners, a private equity investment firm. |
|---|---|
| Transferring Party | VWR International, Inc., a leading distributor of research and lab products to pharmaceutical, biotechnology, chemical, technology, clinical, food processing and consumer product companies, and other accounts. |
| Sector | Diagnostics |
| Date | June 29, 2007 |
| Analysis With $3.1 billion in global sales, VWR sells lab products such as chemicals, glassware and plasticware, safety equipment and instruments to more than 250,000 customers, primarily in North America and Europe. Madison Dearborn owns several distribution companies and is bullish on lab distribution. German drugs and chemicals group Merck KGaA sold VWR to buyout firm Clayton, Dubilier & Rice in '04 for $1.68b. Here, CD&R is selling VWR for approx. $3.7b. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |